Outcomes4Me Secures $21M in Funding Learn more >>

ADVERTISEMENT

What kind of B-cell lymphoma do I have, and why does it matter?

August 30, 2026

women on medical checkup

If you’re newly diagnosed with lymphoma, one of the first and most important things to understand is that “B-cell lymphoma” is not a single disease. It’s a family of related blood cancers that start in B-lymphocytes, a type of white blood cell that normally helps fight infection. More than 30 subtypes of non-Hodgkin lymphoma have been identified, and getting oriented to where your diagnosis fits in that bigger picture is one of the most grounding things you can do in these early weeks.

Two of the more common types you may hear about are diffuse large B-cell lymphoma (DLBCL), the most common form of B-cell lymphoma, which tends to grow quickly, and follicular lymphoma (FL), which is typically slower-growing. There are other subtypes too, including rarer forms like primary mediastinal B-cell lymphoma and high-grade B-cell lymphoma, and sometimes a slow-growing lymphoma can transform into a faster-growing one over time. This is actually a fairly well-recognized pattern, and one reason doctors keep a close eye on indolent lymphomas even when they aren’t causing symptoms yet.

This is why the pathology report matters so much, even though it can feel like reading a different language. CD20-positive describes proteins found on the surface of the lymphoma cells. CD20 is significant because several modern lymphoma treatments are designed specifically to target cells that carry it. You may also see references to your lymphoma’s “grade” (how the cells look under the microscope) and “stage” (how much of the body is involved, often described using imaging like a PET/CT scan). Staging isn’t just a technicality, it’s one of the main things that shapes which treatments are considered appropriate for you.

A few things worth doing in these early days:

  • Ask for a copy of your pathology report and ask your care team to walk through it with you in plain language, term by term if needed.
  • Confirm your specific subtype and stage. It’s completely fair to ask your doctor to write these down for you, since you’ll likely be asked about them again by other providers, pharmacists, or insurance representatives.
  • Ask whether a second opinion or a lymphoma specialist consult makes sense. Because B-cell lymphomas are a specialized area, many general oncologists welcome input from a lymphoma-focused center, especially for less common subtypes.
  • Write down your questions before appointments, and consider bringing someone with you to take notes. It’s easy to blank out once you’re in the room, even for questions you rehearsed at home.
  • Reach out to a patient organization early. Groups such as Blood Cancer United (formerly the Leukemia & Lymphoma Society) offer free, one-on-one conversations with information specialists who can help you understand your specific diagnosis in everyday language, at no cost.

It’s also worth naming something that doesn’t always get said out loud: understanding your diagnosis is partly a way of taking back a little control in a situation that otherwise feels like it’s happening to you rather than something you’re a participant in. Many patients describe the period right after diagnosis, before a treatment plan is even in place, as the hardest emotional stretch of the whole experience, simply because so much still feels unknown. That reaction is completely normal, and it tends to ease somewhat once a plan starts to take shape.

It also helps to know that you don’t have to absorb all of this information in one sitting. Most people find that understanding sinks in gradually, over several appointments, rather than all at once in the room where the diagnosis is first delivered. 

Don’t be afraid to ask your doctor to repeat something or explain it a different way, especially when you’re processing it under stress. You can also ask to record consultations on your phone specifically so you can revisit them later, once the initial shock has settled and you’re able to take in more detail.

It’s also worth asking early on whether genetic or molecular testing was done on your biopsy sample, since some subtypes are further classified by specific genetic features that can influence prognosis and treatment choice. Not every patient needs this level of detail immediately, but knowing it exists and asking whether it applies to your case is a reasonable question to raise at your first few visits.

Understanding your specific diagnosis won’t make the news easier to hear, but it will put you in control so you can be an active participant in your care.  

Disclaimer: The information provided in this article is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Outcomes4Me is not acting as your caregiver, and any suggestions or guidance offered should not replace the advice of your healthcare provider or qualified medical professional. Always seek the guidance of your physician or other qualified health provider with any questions you may have regarding a medical condition.

ADVERTISEMENT

More Articles